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A B S T R A C T
As a result of recent advances in cancer research and “precision medicine” approaches, i.e. the idea of treating
each patient with the right drug at the right time, more and more cancer patients are being cured, or might have
to cope with a life with cancer. For many people, cancer survival today means living with a complex and chronic
condition. Surviving and living with or beyond cancer requires the long-term management of the disease, leading
to a significant need for active rehabilitation of the patients. In this paper, we present a novel methodology
employed in the iManageCancer project for cancer patient empowerment in which personal health systems,
serious games, psychoemotional monitoring and other novel decision-support tools are combined into an in-
tegrated patient empowerment platform. We present in detail the ICT infrastructure developed and our eva-
luation with the involvement of cancer patients on two sites, a large-scale pilot for adults and a small-scale test
for children. The evaluation showed mixed evidences on the improvement of patient empowerment, while
ability to cope with cancer, including improvement in mood and resilience to cancer, increased for the parti-
cipants of the adults′ pilot.
1. Introduction
As a result of recent advances in cancer research and “precision
medicine” approaches, i.e. the idea of treating each patient with the
right drug at the right time, more and more patients are being cured, or
might have to cope with living with their cancer, which is increasingly
considered a chronic disease [1]. Cancer as a chronic illness is among
the most prevalent and expensive health problems worldwide [2].
Surviving and living with or beyond cancer is rising, for example in the
United Kingdom [3] at an estimated rate of 3.2% per year. These ever-
increasing numbers lead to an urgent need for cancer patients taking an
active and leading role in their rehabilitation, supported by the corre-
sponding healthcare providers. This shift from acute to chronic care
brings emphasis to self-management of cancer, where patients need to
have an active and informed role in managing psychological, physical
and social aspects of their health. As chronic disease management will
continue to be an important component of health care, the identifica-
tion of self-management processes for cancer [4] can greatly help to
guide clinical practice and future research in supporting self-manage-
ment efforts and integrated care.
Integrated care requires health and social care workers, from mul-
tiple professional backgrounds and different organizations, to work
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together – frequently through virtual platforms. ICT plays a vital role in
supporting this team-oriented way of working [5,6], where profes-
sionals must share information about – and with – the patient in real
time so as to provide high-quality, people-centred, coordinated care.
This need has already been identified by several social media platforms
for patients (e.g. PatientsLikeMe [7], Patient Empowerment Network
[8], and CancerConnect.Com [9]), cancer specific mobile apps (e.g.
Cancer Blockade, Breast Cancer Diagnosis Guide, My Cancer Manager,
iCANcer, Cancer Coach, Pocket Cancer Care App, Breast Cancer Diary,
Cancer.Net Mobile) and projects (e.g. p-Medicine and MyHealthAvatar
projects). However, an integrated approach for collecting and in-
tegrating the currently fragmented technologies, for all involved sta-
keholders, such as serious games, personal health systems, decision
support tools, careflow management tools etc. is still missing.
In such a context, the iManageCancer project, an EU funded project
under the European Union′s Horizon 2020 research and innovation
programme, focused on offering effective solutions to all aforemen-
tioned areas, based on the concept of patient empowerment, and con-
tinuity of care. Continuity of care is concerned with quality of care over
time. It is the process by which the patient and his/her physician-led
care team are cooperatively involved in ongoing health care manage-
ment toward the shared goal of high quality, cost-effective medical care
[10]. The central objective of the project has been to motivate the
cancer patient to take a more active role in the management of his/her
disease. In so doing, the patient is to be supported by a dedicated ICT
platform that offers a range of mHealth services aiming to (i) assess and
improve his/her psycho-emotional status, (ii) improve his/her under-
standing of the disease (iii) involve more efficiently his/her family and
treating physician in the disease management process.
As earlier stated, the technologies required to support integrated
care are still missing [11]. As a result, a novel ICT infrastructure has
been developed, designed in accordance to the needs of both the care
providers and the patients, focusing on cancer self-management and on
individual′s wellbeing. The platform puts emphasis on monitoring and
the reduction of adverse events of cancer related therapy, on tools for
monitoring the psychoemotional status of the patient and on tech-
nology for self-motivation and goal setting. Since continuity of care is a
central objective, the infrastructure and its services offer seamless in-
tegrating, and sharing of information amongst the members of the care
team, the informal care givers and the patient her/himself.
This paper provides details on the infrastructure developed within
the project, based on a co-design development process, and presents the
results from its evaluation studies. More specifically, within the
iManageCancer multiple apps have been developed such as the iPHR,
the iManageMyHealth, the iSupportMyPatients, the Serious Games and
the MyHealthAvatar4IMC offering a unique user experience to patients,
doctors/researchers, family members and caregivers. In this paper, we
will focus on the most novel ones, selected for extensive piloting in
clinical studies:
• The iPHR, a personal health system for the patient with a set of
novel intelligent apps such as the Personal Health Information
Recommender, the alerts mechanism and a psychoemotional pro-
filer.• The two serious games developed, one for adults focusing on bal-
ancing life aspects, and one for kids focusing on social support and
for patient psychological support• The decision support tool enabling the definition and execution of
careflow models.• For accessing, the heterogeneous information collected by the pro-
ject an effective data management layer ensures the persistence of
all data and the integrated access to them via a semantic uplifting
mechanism.
In addition, we provide short descriptions for the remaining com-
ponents of the infrastructure. For supporting all these applications, an
appropriate security layer ensures granular access to information,
compliant with European and national legislation. The flexibility of our
approach is demonstrated by the fact that multiple, heterogeneous
workflows and applications work harmonically for empowering pa-
tients. In fact, besides the individual novel components, a key novelty of
the platform lies in the integration of all these tools in a unique infra-
structure easily offering as a whole a vast amount of services for pa-
tients and care providers. We argue that its novelty lies in the proposed
integrated technological infrastructure that enables effectively and ef-
ficiently continuity of care, it empowers patients and their relatives
through an ICT based self-management service platform to better
manage the cancer disease in all phases of the care continuum in col-
laboration with their healthcare providers. All involved participants can
now be cooperatively involved sharing useful information and insights
in ongoing health care management towards the shared goal of high
quality medical care and improving the patient quality of life. It further
allows patients, through an easy-to-use interface for mobile devices, to
keep track of their health and disease status, of therapies and results of
clinical interventions or tests, and to keep a health diary on personal
clinical observations, such as side effects of therapies, which the patient
can share with his healthcare providers. The benefits of our approach
are depicted by the corresponding evaluation results collected, showing
that indeed when used by adults improved coping with cancer, mood
and cancer resilience.
A preliminary, abridged version of this paper presented the first
version of the developed architecture [12]. The current paper extends
the previous one in many ways. First, it details the final architectural
specifications of the platform, showing the final components and their
interactions. It focuses on the most novel ones, offering additional de-
tails for those, providing only short descriptions for the other compo-
nents. In addition, it also presents the semantic layer in details and most
importantly, it provides and discusses results from evaluation in the two
pilots.
The rest of this paper is structured as follows: In Section 2 we pre-
sent related work and in Section 3 we elaborate on the methods. In
Section 4, we provide details on the technical architecture of the plat-
form and the various layers developed. Then, Section 5 presents results
from our evaluation and Section 6 provides a discussion on the lessons
learnt and the limitations. Finally, Section 7 concludes this paper and
provides directions for future work.
2. Related work
In this section, we review similar approaches, highlighting the no-
velty of the developed platform. Surveys on ICT-based patient em-
powerment for cancer patients [13 14] have already identified several
key components for patient empowerment (namely, educational ser-
vices, patient-to-patient services, electronic patient outcome services,
portal services and multicomponent ones) showing that IT services are
important, by providing knowledge to patient empowerment. On the
other hand recent research [15] has identified that for apps developed
for patient empowerment of cancer patients, sources and references
were absent in almost 80% of the descriptions. In addition, 20% of the
apps for cancer management contained gamification elements. Fur-
thermore, 75% of these apps was not promoting at all the commu-
nication with health providers, lacking of such functionalities. Never-
theless, a meta-review on cancer related information [16] identified
that evidence exists for positive effects of ICT technology on perceived
support, knowledge, and information competence of cancer patients.
However, outcome effects for cancer patients are limited and show
mixed evidences. In fact, in several cases, e.g. [17], evidences do not
support the hypothesis that ICT tools used can indeed increase self-ef-
ficacy for comping with cancer mainly because of methodological
reasons. Those surveys highlight the need for an integrated platform,
developed based on a sound methodology, supporting the integration
between the patients and health providers, focusing on patient
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empowerment, offering clinically validated information and support,
and highlight the need for evaluation of the developed technologies.
To this direction multiple decision aid systems have been developed
for helping patients to make informed decisions for prostate cancer
screening [18] and treatment [19] and for breast cancer surgery [20],
however offering simplistic support and with limited evaluation. In
addition, questionnaire-based tools for systematic monitoring the
mental health of cancer patients [21] and their fatigue [22] and for
supporting clinical decision support , self-reporting and self-manage-
ment [23] (e.g. the PROMT-Care system [24]) or for enhancing patient-
physician communication (e.g. the LOOP system [25]) are currently
available. Furthermore, multiple serious games have been developed
for cancer. For example [26] and [27] focus on patient education for
increasing drug compliance, decreasing physical side effects of che-
motherapy and improving psychological status, [28] and [29] track the
level of pain, and [30] promotes social integration of kids and adoles-
cents with cancer treatment.
However, all these attempts present a highly fragmented landscape
of tools for cancer management, as they focus on a very specific area
neglecting the fact that cancer means living with a chronic and complex
condition. Within the iManageCancer project many diverse tools have
been developed, like the aforementioned ones (e.g. a decision aid that
helps the patient to make informed decision on cancer screening and
treatment, multiple online questionnaires available for patient pro-
filing, multiple communication tools between the patients and with
their care providers, serious games etc.). However, the developed so-
lution goes far beyond the individual functionalities of those modules
creating a whole ecosystem for the management of cancer, enabling
actual integration of patients and health providers and continuity of
care, finally empowering patients in collaboration with their health
providers.
The limitations of the various fragmented approaches have already
been identified by multiple research projects as well. For example the
ACGT project [31] tried to provide a novel infrastructure for advancing
the clinico-genomic trials on cancer, whereas the INTEGRATE project
[32] tried to deliver solutions for advancing clinical research and en-
abling multidisciplinary collaboration on cancer. However, although
patient empowerment was among project′s objectives, the notion of the
participatory aspect of the patient empowerment was not investigated.
p-Medicine [33] was among the first projects to focus on patient em-
powerment trying to offer personalized patient services in the form of a
Personal Health Record, whereas MyHealthAvatar [34] was delivering
e-health infrastructures partially covering some cancer scenarios. To
the best of our knowledge, there is no other available platform enabling
the health and psychoemotional monitoring for cancer patients, aug-
menting communication with doctors, offering decision support tools
and many added-value health services.
3. Methods
An overview of the research and development methodology of the
iManageCancer project is shown in Fig. 1. It is consisted of four main
phases:
Design phase. In order to identify the technological solution to be
developed, we initially relied on an extensive literature review on ex-
isting platforms for cancer self-management and a survey collecting the
perspective from clinicians, psychologists, patients and citizens (an-
swered by 226 adults) [36]. The survey helped us to understand on one
hand the needs of citizens and patients from a platform like iM-
anageCancer and on the other hand, to get feedback from end-users on
what kind of scenarios were relevant for them. Using this information,
the most important use-case scenarios were established, from an end-
user perspective. In addition, three white papers from a research,
publishing and consultancy group called PatientView were analyzed:
1. White paper ‘What do people want from health apps?’ [37].
2. White paper ‘Health apps: Where do they make sense?’ [38].
3. White Paper ‘What do patients and carers need in health apps – but
are not getting?’ [39].
As a result, fourteen scenarios were created for helping patients to
manage their disease in all aspects. Those scenarios were transformed
into formal use cases and technical system requirements [40] and the
key components were identified, required to deliver the envisaged
functionalities. In the next step, these technical requirements were
further validated and analyzed in order to provide input for establishing
the system architecture, identifying the various components and their
interactions. Same or similar requirements were summarized and
merged, while some requirements were assigned to multiple compo-
nents or services. Apparent conflicts were identified and resolved. Then
the first version of mockups were generated. In an iterative way, led by
the clinical partners, the scenarios and the respective mock-ups of the
system were further refined. For this purpose, a first workshop took
place for the consortium members and patient representatives, and then
those results were also presented to a joint workshop with the EURECA
(Enabling information re-Use by linking clinical Research and Care)
project, resulting in further elaboration of the scenarios and the
mockups.
Development phase. The development of the iManageCancer tools
and services was based on an iterative process, which included clin-
icians, patients and other end-users right from the beginning of the
process assigning them the responsibility to thoroughly test the us-
ability and the functionality of the overall platform. Trying to identify
whether the developed tools meet the end-users expectations, we in-
tegrated risk management activities in the software life cycle manage-
ment. In addition, we adopted a software validation process based on
the ISO/IEC25000 [41] series. In order to assure the quality of the
desired outcome, the developed software was constantly being vali-
dated during and at the end of each development iteration. This vali-
dation was performed by internal clinicians and external patient asso-
ciations, guaranteeing the effective co-design of the final solution. As
such, during the development, several identified obstacles were re-
moved in an iterative process between users and developers. For ex-
ample, although there were problems with the usability of the platform
at the beginning, after two development iterations usability problems
were resolved.
Fig. 1. Methodology of iManageCancer platform.
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Evaluation. The platform was developed with the objective to im-
prove the degree of involvement of cancer patients′ in their own care
process. The apps and their functions support patients in getting a more
active role in their healthcare pathway. Since the disease has an effect
on the emotional sphere of the patient (positively or negatively), key
research questions were to identify whether using the app′s functions
would influence patients′ mood and cancer resilience and whether
using the platform has an impact on patient engagement. In addition,
we wanted to identify whether the platform and its services can affect
patients′ cognitive/attitudinal base, enabling them to increase their
awareness about their condition.
To achieve these objectives, two studies have been conducted. First,
a study with adult patients which was focused on evaluating the effects
of the app usage among breast and prostate cancer patients, according
to the objectives highlighted above; second a small-scale testing in-
volving children, which collected anecdotal information on usability
and interaction with the application through semi-structured inter-
views; Both studies were established during the lifetime of the project
and all administrative regulations according to GCP criteria for clinical
trials were successfully solved including ethical approval. Patients
could be entered into the trial during the last year of the project. In the
sequel, we provide more details on the two specific studies:
Pilot for adults: The objective of this study was to analyze patients′
response to the usage of the iPHR app. As a preliminary evaluation,
experts from the consortium used the application to report possible
malfunctions or usability issues. Secondly, patients who declared using
the platform were asked to respond to a usability questionnaire adapted
from the Systems Usability Scale [42]: these data were used descrip-
tively to account for the app reaching a satisfactory usability score, and
were not included in further analyses. Next, the research group iden-
tified relevant constructs to analyze patients′ empowerment, namely
resilience, which regards the ability of people to resist and manage
negative experiences and trauma; since the application is expected not
only to provide entertainment and positive emotions but to help pa-
tients to exercise psychological abilities, it is possible that their resi-
lience ability would be influenced by the continual use of the applica-
tion resources. Secondly, it was considered important to evaluate
changes in patients′ attitudes toward cancer, in terms of their motiva-
tion and ability to confront it and to manage illness and therapy.
Thirdly, the application usage, as well as the experience of the disease
per se, could affect mood and emotional responses, which are an im-
portant component of perceived quality of life. For this reason, it was
important to analyze patients′ emotional state before and after the
usage of the application (or, of the informational material in case of the
control group). Finally, we wanted to see whether the application
(expected group differences) or the continual experience of a disease to
manage (expected pre-post differences) were associated to higher pa-
tient empowerment/engagement, namely commitment by patients to-
wards their own care journey.
For the adult′s pilot, the inclusion criteria were a diagnosis of early
stage breast or prostate cancer, age between 18 and 75, IT literacy and
undergoing active oncologic treatment (surgery, chemotherapy or ra-
diation therapy). Exclusion criteria were psychiatric comorbidities,
metastatic disease, or impairments to fill questionnaires or sign the
informed consent. In addition, a number of psychological states related
to patients′ activation/involvement in their own care were used.
Specifically, the Resilience Scale for Adults [43] and the Mini-Mental
Adjustment to Cancer scale (Mini-MAC) [44] have been used to analyze
changes in patients′ attitudes towards their own situation. Indeed, these
tools analyze patients′ tendency to manage their own state in a more or
less functional way; as explained already, we expected that the usage of
the application could have influenced patients′ ability to confront with
the diseases. The first tool measures resilience or the ability of adap-
tation in the face of significant losses, trauma or suffering, as well as the
ability to find positive outcomes within adverse circumstances; this has
been used to track possible changes in patients′ psychological strengths
related to the use of a health management tool. Diversely, regarding the
importance to analyze patient′s attitude towards cancer, the Mini-MAC
questionnaire [19] has been used, which includes subscales such as
“avoidance” (patients′ tendency to not-deal with the disease so to avoid
emotional suffering), and “fighting spirit” (attitude towards actively
combating the illness). This tool is useful to account for specific changes
(both positive and negative) in patients′ personal approach to illness
and health management, which is possibly influenced by having novel
technological tools to conceptualize, experience and manage illness.
Additionally, the Profile of Mood States [45] has been used to in-
vestigate changes in patients′ emotional state, in order to account for
fine-grained aspects of the emotional reactions to the care process
mediated by the tool. Finally, in order to respond to the third objective,
patients′ involvement in their own health was used as a primary end-
point and was measured using the Patient Health Engagement Scale
[30]. This is an evidence-based measure of the patient′s involvement, as
an active human resource, in his or her own care process, which is a
complex construct comprising cognitive (e.g., performing effective
health decision-making), behavioral (e.g., adhering to therapy) and
emotional aspects (e.g., being able to manage stress and illness-related
negative emotions).
Patients respecting the inclusion criteria were proposed to take part
in the study by one of the members of the iManageCancer team in IEO.
After written informed consent, they were randomly assigned to one of
the study groups (eHealth Intervention (eHI) vs. Information Material
(IM); see below). Randomization was stratified by cancer site. At the
beginning of the study (T0), all patients underwent a paper-based as-
sessment that included a Case Record Form collecting socio-demo-
graphic information, disease characteristics, past and current treat-
ments. The administration of the questionnaires described in the
endpoints section the assignment to one of the study groups.
Patients in the eHealth intervention (eHI) group were given a
smartphone equipped with the iManageCancer platform at T0. They
could use the platform for 6–10 weeks depending on their consultation
schedule. Patients assigned to the Informative Material (IM) group
followed the standard care flow and were given standard informative
material about their disease usually provided by the hospital. After
6–10 weeks (depending on the appointments scheduled by the clin-
icians), all patients underwent the same assessment as T0. Three to five
months after the beginning of the study, clinical performance indices
were evaluated.
Small scale test with children: In most cases, children cancer can be
cured today with an overall survival rate of more than 80%. This im-
provement is mainly due to enrolment of children with cancer in pro-
spective randomized clinical trials, basic research and empowering of
parents of children with cancer [46]. The pilot for children aimed to
evaluate the iManageCancer platform and its services in practice re-
garding feasibility, acceptance, usability, performance, costs, and out-
come on quality of life of cancer patients. The pilot passed all reg-
ulatory bodies and ethical approval was given by the Ethical Committee
of the ‘Ärztekammer des Saarlandes’ (No.: 96/17, 18th July 2017). As
cancer in childhood affects always the whole family, parents and their
ill child were invited to take part in this pilot by giving informed
consent. After registration in the iManageCancer platform parents au-
tomatically received credentials for the game for kids and access to the
iMC platform. For the following 6 months, parents and children were
asked to use the IMC platform and play the game for kids. At the end of
the 6 months, parents were interviewed to evaluate the platform, tools
and the serious game for kids.
4. Proposed model
The architecture of the iManageCancer technological infrastructure,
shown in Fig. 2, was generated as a result of three development cycles
and constant user interaction. It consists of five layers: a) the applica-
tion layer that provides all functionality through a rich graphical user
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interface, b) the central decision support framework enabling in-
telligent decision support, c) the security layer ensuring selective access
to the available information, d) the semantic layer integrating all
available information and the e) data storage layer enabling the per-
sistence of all available data.Fig. 3.
The implemented platform follows the patient/user centered design
principles and its security mechanism is not an exception. The patient is
the owner of his/her data and controls the access to the data from
others such as the doctor or a friend. The platform supports author-
ization (using the industry standard protocol OAuth 2.0), authentica-
tion, delegation, auditing for secure access and for the communication
between services and a flexible data sharing mechanism. Every patient,
Fig. 2. The high-level architecture of the iManageCancer platform.
Fig. 3. Sharing available data with own networks.
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registered to the platform, can upload various kinds of data. As these
data are private and confidential, specific requirements for data pro-
tection have been addressed including https protocol, roles and rights
management system, encrypted disk and database, while secondary
usage of data is available only after consent and anonymization. The
following sections describe in more detail each one of the remaining
layers in detail.
4.1. The iManageCancer PHR portal
For the patients, the intelligent Personal Health Record (iPHR), is
the central access point. It is accessible through all mobile devices
(laptops, mobile phones, tablets etc.) and contains a collection of in-
dividual application that can be activated at will. They can be cate-
gorized as follows:
Apps for collecting health information: This category includes apps for
recording and visualizing patient health information (problems, medi-
cations, procedures, allergies, immunizations, laboratory results and mea-
surements apps).
Health Management apps: This category includes apps enabling the
active management of health related issues and patient engagement.
Such applications include an intelligent e-diary where all available in-
formation is visualized using timeline and calendar views, an appoint-
ment app for recording and reminding doctor appointments and a
documents app for uploading existing medical documents (discharge
letters, images etc.). In addition, a patient is able to actively share his
information with selected persons or groups.
Intelligent apps: In this category there are multiple apps exploiting
intelligence in order to provide various recommendations to patients.
For example, the Personal Health Information Recommender [47] is a
semantic [48] search engine and a recommendation system, which
enables patients to search for health related information in a set of
relevant documents selected carefully by domain experts. The alerts
mechanism identifies predefined correlations between measurements,
medications and laboratory results and is able to notify patients to
contact their doctor if needed.
Psychoemotional apps: This category includes applications [49] that
enable monitoring of the psychoemotional status of a patient though
the ALGA-C and the Psyche online questionnaires, to capture the family
status through the Family Resilience Questionnaire and the Parental Dis-
tress and to enable decision making through the Decision Aid app.
Apps for doctors and researchers: The apps in this category include
apps able to provide overviews of the patient information and for
analyzing the patients′ data providing all necessary information to the
doctor for decision-making. As such, the Profiler app constructs visual
profiles of the patient psychoemotional status with guidelines for the
doctor on how to interpret each result. Furthermore the Smart Analytical
Framework (SAF) [50] enables cohort analysis and exploration of the
available data shared with individual doctors.
4.2. The MHA4iMC and the iManageMyHealth app
The MHA4iMC app has been developed for the cancer patient em-
powerment, supporting the daily management of their lifestyle and
promoting a healthy living. It helps patients to monitor, record and
manage all their activities and physical exercises offering a unique tool
for self-data collection. In addition, it focuses on patient education by
providing information on potential risks, diet choices, and exercising
and reduces related risks increasing their compliance with re-
commendations for healthy living.
The mobile application iManageMyHealth provides support for pa-
tients to successfully manage an increasing number of prescribed drugs
and to generate warnings for dangerous interactions between them. The
interactions of the application with other components is shown in
Fig. 4, whereas the user interface is shown in Figs. 5 and 6.
The medication management app offers functionality to easily
create a medication plan including information about prescribed drug
intakes like dosage, frequency, drug intake time(s) and corresponding
reminders. The patient is also able to report adverse effects and out-
comes that have been witnessed.
By leveraging public drug repositories, drugs in the medication plan
are automatically checked if active ingredients of drugs affect each
other when administered together. The interaction can be antagonistic
or synergistic. Antagonistic means that the drug′s effect is reduced
whereas synergistic means that it is increased. In some cases, drug in-
teractions can lead to a new effect that the individual drugs do not
produce. As such, the app provides information on these interactions
and supplementary functionality to view the drug taking history, and to
get structured information about a drug like instruction leaflet.
The drugs in the medication plan can be also scanned for contra-
indications due to patient′s reported diseases and health status. For
example, some medications might only cause adverse events in people
with specific allergies, in case of pregnancy, diabetes, high blood
pressure etc. Additionally, the app performs quality checks, e.g. if the
dosage for the patient is correct according to age and weight data as
recorded in the patient′s profile.
The multifunctional app also allows patients to record measurement
values when using medical devices for blood pressure, weight, and
temperature monitoring. Devices from specific vendors can be directly
connected with the smartphone via Bluetooth Low Energy protocol. The
measurements are stored in the local database and optionally in the
iManageCancer data store using the security infrastructure of the
platform. They can be viewed as graphs on the smartphone and on the
iManageCancer portal as well.
The patient can edit his profile information, access the own records
on the iManageCancer platform. Further to this, he can take pictures of
his paper based clinical documents and add them to the own health
profile and get additional information on terms that he does not un-
derstand. The medical documents can be optionally synchronized with
the iManageCancer portal.
4.3. Serious games
iManageCancer focused on implementing two serious games, one
for adults and one for children.
For adults: The serious game for adults, shown in Fig. 7, has the
objective to educate patients on healthy lifestyle in an entertaining way.
The game has to do with balancing between the different aspects of life
for virtual characters in the game. As such, the patients can understand
how the choices they make regarding lifestyle, diet and exercising af-
fects their well-being and are able to translate these key lessons in their
individual life. The app is communicating with the iManageCancer
platform for capturing statistics, whereas at the same time offline
playing is also supported. In addition, the players can exchange com-
ments and score on social networks.Fig. 8.
For kids: “Boosters” is a serious game for children and adolescent.
Fig. 4. ManageMyHealth app interactions.
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The game combines the elements of a classical shooter game and a
match game (like “Candycrush”) with social aspects. The screenshot in
Fig. 7 shows a scene from the shooter game.
The game is developed for the two most important operating sys-
tems of mobile devices, iOS and Android. It can be played on both
smartphones and tablets. In the shooter game, the players travel with
their vessel through the human body and fight various types of virtual
cancer cells using multiple weapons gained by their supporters. The
different weapon types are aligned with the different therapeutic op-
tions available in cancer treatment.
As such, the game sends out the message that patients themselves
can play an active role in the combat against cancer – and that weapons
do exist. Also, social aspects are included in the game, as family
members and friends can act as the player′s supporters, who send to
them extra weapons, extra damage shields and – simply, but maybe
most importantly - attention. An important finding that came out from
the evaluation activities of the serious games is that there is a need to
have a deeper understanding of the game′s target, so a child-friendly
tutorial mode was added.
Fig. 5. Start page and main menu.
Fig. 6. Medication plan and drug intake times.
Fig. 7. Serious game for adults.
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4.4. The decision support tool
Clinical decision support systems (CDSS) cover a wide range of
health applications spanning across health economics, adverse events
alerts and patient satisfaction. Main objective of CDSS is to improve the
healthcare quality while the most recent approaches focus on the in-
formation [51] and intervention [52] delivery to the appropriate person
at the right time, during the healthcare process. Another discipline of
CDSS is to fill the gap between clinical research and practice acting as
knowledge mediator of the research findings to the clinical care setting.
The decision support layer of iManageCancer platform provides a
central point for clinical decision support for the health providers able
to offer appropriate guidance based on the presented results, as shown
in Fig. 9. The iManageCancer CDSS takes advantage of state of the art
clinical knowledge, patient/personal data, and healthcare delivery
models in order to support patients and clinical experts in the decision
making process for treatment choices and management of side effects.
The iManageCancer CDSS currently includes the following apps: the
iManageMyHealth, the iSupportMyPatients, the Care Flow Engine
(CFE), the Care Flow Designer (CFD) and the Model Repository Fra-
mework (MRF).
The execution of the (formal) disease management pathways, also
called care flows [53], is delivered by the CFE. CFE has been the result
of a co-design process between clinical domain experts and in-
formaticians. It provides an intuitive user interface as formal disease
management workflows [54] and uses rules that operate on patient′s
health information to deliver appropriate treatment paths. The iM-
anageCancer CFE is a highly innovative technological output of the
project that follows a patient catered approach and supports the co-
management of his/her health. The care flows follow the Business
Process Modell and Notation 2.0 (BPMN) while for the execution the
open source platform Activiti (https://www.activiti.org/) has been
deployed.
Furthermore, the system is integrated with the Model Repository
Framework (MRF) [55] and can invoke predictive models tuned for
identification of optimal treatment plans. The MRF framework (Fig. 10)
supports a variety of multi-scale models such as combined community-
developed models (e.g. the St. Gallen risk model) and knowledge
models from relevant research (e.g. Oncosimulator [56], MinePath
[57], microRNA model [58]) in the oncology domain. Fig. 11
With the help of the CFD, experts can design new Care Flow models,
involving time triggered tasks and predictive models and can deploy
them as executable workflows in the CFE. The care flows are interfaced
to a user′s mobile application providing recommendations for the op-
timal management of cancer in various aspects such as fatigue, pain or
the monitoring of chemotherapy.
The iManageCancer platform is a service-oriented, modular infra-
structure providing a high degree of autonomy and automation and the
designing of meaningful care flow diagrams is not an exception. The
iManageMyHealth and iSupportMyPatients apps provide clients that
use the care flows for their execution, and can process tasks for the
healthcare provider and the patient by the CFE.
Care flow models take also into account self-assessment data from
the patient and their clinicians. Specialized questionnaires dedicated to
health assessment and measurement tasks have been integrated into the
iManageMyHealth app. Data from the different sources is compiled and
advice is given as information tasks or linked with the personal medical
information recommender [59] that provides high quality public in-
ternet resources on cancer.
The iSupportMyPatients app supports the healthcare professionals
who can download and process tasks for their patient′s.
iSupportMyPatients and iManageMyHealth apps are integrated with the
CFE enabling them to receive notifications about tasks assigned.
4.5. Data management & semantic layers
To enable effective and efficient data access to all information col-
lected through the various applications and tools a data management
infrastructure has been set up [60,61]. It consists of the data lake, the
iMC semantic core ontology and a set of data integration tools. These
will be described in detail in the sections to follow.
Fig. 8. Serious game for kids.
Fig. 9. The iManageCancer care flow decision support layer.
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5. The data lake.
The bottom layer of the data management infrastructure is an in-
stantiation of the data lake. In this data lake multiple, heterogeneous
databases exist offering different options for managing and accessing
the stored data. For example various components use relational data-
bases (e.g iPHR), that offer SQL-based APIs, others might use NoSQL
databases (e.g. MHA4IMC) that offer CQL-based APIs etc. In addition, a
triple store is available storing individual data sources such as drug
interactions and selected integrated information resulted from the data
integration tools.
6. The IMC semantic core ontology
For conceptually modeling the cancer domain and capturing all
relevant data, the iManageCancer project reuses and extends the
MyHealthAvatar Ontology Suite [34]. The resulting ontology consists of
48 subontologies, most widely used in the health domain integrated
through mapping relationships. Based on this ontology all available
data can be mapped to appropriate terms from this ontology and
eventually integrated using the data integration tools.
7. Data integration tools
The data integration tools can get the mappings [35] between the
iMC Semantic Core Ontology and the data sources and enable trans-
parent access to them through a SpaRQL endpoint. In addition, the used
tools can materialize the integrated information to be further stored in
the available triple store. As such, we can both access always the latest
information, sacrificing execution time or access the data through their
integrated instance available in the triple store, sacrificing access to the
latest data. Both approaches are used in the iManageCancer project
depending on the various requirements of the tools.
As SpaRQL is not a common language to be used by developers,
multiple APIs have been implemented on top for accessing the in-
tegrated information. In addition, direct access to the data lake is also
possible, using additional data access APIs.
8. Evaluation results
In this section we report the evaluation results for the one main pilot
and then for the small-scale study with children.
Fig. 10. The models repository framework.
Fig. 11. iManageMyHealth app, care flows (left) and questionnaires (right).
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8.1. Pilot for adults
In the pilot for adults, 135 patients were recruited: 88 women with
breast cancer and 47 men with prostate cancer. The characteristics of
the sample are shown in Table 1.
During the 6–10 weeks in which the patients tested the platform,
they reported some common issues or useful comments for the im-
provement of applications. The most significant problems were the
technical difficulties in using the app, due to internal bugs in the apps
and to some patients′ lack of smartphone knowledge. Patients also re-
ported issues in managing two smartphones, their own and the project
one in addition, and in finding the time to use all the apps. A few pa-
tients also stated that they could not use the app because of the stress
caused by the platform constant reference to cancer.
The results from the usability evaluation for adult patients that
followed are shown in Fig. 12. Some key observations are that 90% of
the patients agreed on that the platform is an added value for the
hospital, 54% of the patients rated the platform in general above
average and 67% of the users agreed that the system was easy to use.
Finally, 74% of the users found the various features of the platform
useful. Overall, the usability evaluation showed that the system was
relatively easy to use and comprehend with interesting functionality,
offering a benefit to the health organizations.
For what regards usage frequency, participants had more accesses
(both total and mean) to the iPHR app in the first weeks, while accesses
decreased in the last weeks of the intervention (see Table 2). It is im-
portant to consider that the usage data showed an inconsistent pattern,
with patients having accesses to the application more times in the first
weeks and less accesses in the last ones: future studies may explore the
causes of such a decreasing beyond a typical “novelty effect”, which are
not necessarily negative (e.g., the patients interiorized soon the abilities
promoted by the app), as well as its influences on final results. Table 3
Mixed design analyses of variance have been conducted on all the
dependent variables, with Group (Experimental vs. Control) as the be-
tween subjects factor, and Time (Pre vs. post intervention) as the within
subjects factor. Resilience measures did not lead to significant differ-
ences between the groups. Mini-MAC showed meaningful differences:
specifically, subscales “fighting spirit”, “anxious preoccupation”, and
“avoidance” reduced in the experimental group after the
iManageCancer intervention; “fatalism”, instead, reduced in both
groups.
Also POMS measures showed significant results, related to differ-
ences between pre and post intervention evaluations: both groups re-
sulted more angry, more confused, more depressed, more indolent,
more anxious but also more active/vigorous after the intervention (see
Table 2 for results and mean values).
Finally, also the PHE scale detected a change in level of engagement
after the intervention in both groups (see Table 2 for results and mean
values).
Results from the adult pilot, showed a complex pattern, especially
regarding participants′ emotional response to diagnosis and treatment.
Specifically, according to POMS measures, participants experienced an
increase in negative emotions and physiological state; being spread
across the whole sample, these changes in mood are probably related to
the disease process and to the late emergence of side effects of medical
therapy. However, at the same time, Mini-mental subscales were able to
capture differences between groups. Those are, reduction in “Fighting
spirit” coupled with reduction in “Anxious preoccupation” in experi-
mental group if compared with the control one. This may be explained
Table 1
Characteristics of the pilot for adults (missing responses excluded).
Group Men Women
Tot recruited 47 88
Age – mean (SD) 61.6 (5.35) 51.4 (8.07)
Residence – N (%) Intra Region
Extra Region
16 (37.1)
26 (62.8)
45 (62.5)
27 (37.5)
Education – N (%) No diploma
Diploma
B.A./M.A
5 (10.9)
31 (67.4)
10 (21.7)
13 (14.9)
44 (55.2)
26 (29.9)
Marital Status – N (%) Married
Never married
Divorced/separated
Widowed
39 (84.8)
0 (0)
6 (13)
1 (2.2)
55 (63.2)
18 (20.7)
11 (12.6)
3 (3.5)
Occupation – N (%) Employed
Self-employed
Manager
Retired
Unemployed
21 (42.6)
13 (28.3)
3 (6.5)
8 (17.4)
1 (2.2)
55 (63.2)
11 (12.6)
3 (3.4)
9 (10.3)
9 (10.3)
Fig. 12. The results (percentages) from the usability evaluation through the adapted SUS questionnaire.
Table 2
Number of accesses to the application by adult participants per week.
week Total accesses per week Accesses per patient (mean)
1 597 4.59
2 84 0.65
3 55 0.42
4 57 0.44
5 21 0.16
6 18 0.14
7 29 0.22
8 12 0.09
9 23 0.18
10 2 0.02
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by considering the interesting result involving Mini-Mental-Avoidance,
which reflects patients′ tendency to “not-think” (not cope with) cancer
diagnosis and its expected effects on future life. Indeed, Avoidance was
reduced in experimental group as well; this could be an indication that,
thanks to the tools offered by the intervention, the patients in the ex-
perimental group were able to deal with the experience of cancer
sooner than their control counterparts. For this reason, they were less
prone to “fight” the disease but also less anxious. This is in accordance
with the patient engagement journey as described by the PHE scale and
the theoretical model behind it [62]; indeed, as patients are evolving
through a more complex representation of the disease and of their life
with the illness, emotional experience is more dramatic than im-
mediately after the diagnosis, when the first evaluations of psycholo-
gical variables were performed. However, when the application is
available, they have more occasions to deal with the disease (not
“avoiding it”) and reduce anxious preoccupation. This is yet another
important result, showing that patients helped by the app have less
tendency to feel anxious about the illness. In this sense, it is possible to
sustain that the iManageCancer ICT infrastructure succeeded in aug-
menting patients′ knowledge and in complexifying their representation
of the disease (first objective). Regarding the other objectives of the
study, mood and emotions appear only partially influenced by the
availability of the application, while patient engagement seems, at the
present time, independent of the application.
Future studies on the platform should include the analysis of the
emotional responses at more advanced phases of patient engagement,
to explore whether the application was useful to improve subjective
quality of life too.
8.2. Small scale testing with children
In this small scale testing the goal was to enroll 23 families with
children with cancer (setting a confidence level of 95% with a con-
fidence interval (margin of error) of 20% to get results reflecting a
population of 1800 patients that represents the whole population of
children with cancer in Germany per year. In addition, a higher number
of children was unrealistic to recruit in the timeframe of the
iManageCancer project, as cancer in childhood is a rare disease with
only 50 new cases diagnosed within one year at the Saarland
University. However only fifteen patients were finally enrolled. This is
because some of them refused to give informed consent (5), were
transferred to another hospital (1) or died within four weeks after di-
agnosis (2).
All families went through a semi-structured interview by a medical
doctoral student. This interview included the following topics:
1. Questions regarding the process for signing the informed consent.
2. Questions regarding the usability of the platform.
3. The level of satisfaction by using the platform.
4. Whether they had to report any non-technical problems.
According to the collected reviews, the patients reported that the
process for signing the informed consent was in many cases too long
(3 days on average) and in some cases, they were overwhelmed by the
amount of information offered by the platform. In addition, some fa-
milies complained about further stress caused by the additional time
required to use the platform and its IT tools at a time in which they
were confronted with the cancer diagnosis. Specifically for the pilot in
children, parents were worried for not been successful in the shooter
game for killing cancer cells; it created additional emotional stress to
them and negatively influenced their acceptance of the serious game.
Many parents were also anxious about storing and sharing personal
health data, which also influenced the usage of the platform, an issue
that is regularly reported as a factor-influencing acceptance of eHealth
and mHealth services [63].
9. Discussion and limitations
Significant advances have been made in cancer care, so that even
when cure is not possible, many cancers can be controlled and managed
for long periods of time. The progress in diagnosis and treatment results
in more cancer survivors, and many strategies have been proposed to
support this population [64]. Many physicians and practitioners con-
sider patients being treated for some types of cancer as living with a
chronic condition. Nevertheless, most of the strategies are based on
group activities and tutoring, while the ICT-based systems of self-
management provide in most of the cases only electronic ques-
tionnaires. The proposed ICT framework, of self-management, for pa-
tients with and after cancer, provides a broader pallet of tools with the
aim to facilitate continuity of care and to enable increased patient
Table 3
Results of the mixed design ANOVAs on the dependent variables (Mini-MAC, POMS, PHE scale); *< 0.05 ; **< 0.01.
Pre-Intervention Post-Intervention Pre-Post comparison Group comparison
Questionnaire Assessed dimensions M (SD) M (SD) F(df) p η2 F(df) p η2
Mini-MAC Fighting Spirit Experimental 15.7 (2.7) 14.6 (23) 2.96 (1.93) 0.089 0.031 6.08 (1.93) 0.015* 0.061
Control 15.01 (3.5) 15 (2.2)
Preoccupation Experimental 16.8 (4.2) 15.4 (3.5) 2.79 (1.93) 0.098 0.029 5.37 (1.93) 0.023* 0.055
Control 15.6 (5.4) 15.7 (4.1)
Avoidance Experimental 11.1 (2.7) 10.3 (2.4) 2.83 (1.93) 0.096 0.03 3.79 (1.93) 0.054 0.039
Control 10.2 (3.1) 10.2 (2.1)
Fatalism Experimental 9.5 (2.0) 9.3 (1.9) 4.10 (1.93) 0.046* 0.042 n.s.
Control 10.3 (2.2) 9.8 (1.9)
POMS Anger Experimental 4.6 (4.5) 9.9 (3.9) 150 (1.89) 0.000** 0.62 n.s.
Control 4.9 (5.2) 10 (4.5)
Confusion Experimental 8.7 (5.4) 13.2 (5.3) 110.6 (1.89) 0.000** 0.55 n.s.
Control 8.3 (5.9) 13.2 (4.9)
Depression Experimental 9.3 (9.8) 23.1 (9.1) 265.2 (1.89) 0.000** 0.74 n.s.
Control 9.8 (11.6) 24.1 (11.0)
Indolence Experimental 6.3 (5.1) 14.1 (5.8) 333.4 (1.89) 0.000** 0.79 n.s.
Control 6.9 (5.9) 14.1 (5.5)
Vigor Experimental 16.3 (5.9) 22.9 (5.5) 193.5 (1.89) 0.000** 0.68 n.s.
Control 14.9 (6.8) 22.3 (6.5)
Anxiety Experimental 9.4 (6.8) 14.3 (5.3) 105.2 (1.89) 0.000** 0.54 n.s.
Control 9.2 (7.0) 15.7 (6.5)
PHE Engagement Experimental 5.1 (1.2) 5.4 (1.2) 4.62 (1.94) 0.034* 0.047 n.s
Control 4.8 (1.5) 5.0 (1.4)
H. Kondylakis, et al. Journal of Biomedical Informatics 101 (2020) 103342
11
empowerment.
Our evaluation results demonstrate that ICT self-management tools
for cancer can improve the psychoemotional status of the patient and
reduce distress, a finding that is in line with available evidence [65].
A key lesson learnt from the implementation nd evaluation activities
of reported in this manuscript is that usability is a major key to success
and that technology pilots should only start when the relevant tools
have reached a high maturity level. However, in order to reach this
maturity level constant involvement of all stakeholders is required and
co-design with the end-users is very important.
Another key lesson is that ‘One-size-fits-all’-approach does not work
for cancer. A platform of multiple services must be further personalised
to individual needs, to reduce the burden of patients to deal with its
functionality. Some patients might not have the digital literacy required
to use them, they might have different priorities and the burden of the
disease/therapy might be too high to try new approaches. In addition,
although we expected that serious games would be very attractive for
kids, we had not foreseen the additional stress that would induce to
them in some cases.
In addition, results demonstrated that the psycho-emotional state of
patients in the first months after the diagnosis tend get more negative
(depressed, angry). Future tools may be used not only to give patients
activities and stimuli, but also affordances to express their own ex-
perience of the lived illness, so that their emotional and attitudinal
response to diagnosis and treatment would be understood more clearly
[66,67].
Furthermore, pilots should be constructed in a way that they assess
only one (or a few) intervention(s) for the specific cancer group, and the
specific phase of the treatment they are designed for. Standardized
clinical guidelines are required to advice patients how to cope with
monitored findings.
Finally, we have to mention that the limited participation in the
small-case study. This fact did not allow us to make a statistically sig-
nificant analysis of the effects that serious games have on patients′
ability and resilience to cope with the disease. Nevertheless, it has
proven to be a very useful intervention, in that it enabled us to discover
the negative effects it had on the patients due to the increased emo-
tional stress induced to the patients. As the platform will be used in
further projects, the pilot for children will continue to seek answers on
how serious games will be able to benefit cancer patients, if such
benefits, do actually exist.
10. Conclusions
Studies have shown that up to two thirds of cancer patients ex-
perience substantial physical, psychological and social problems due to
the disease and treatment [68]. Support from healthcare and social
services is often inappropriate, and patients report high levels of unmet
needs following treatment and even a long time after [69]. One key
such, currently unmet, need is the effective support of continuous and
integrated care [70]. In this paper, we presented the elements of a novel
a novel ICT infrastructure developed and employed for supporting in-
tegration of care and empowering cancer patients to take better part in
the management of their disease. We presented in detail the various
technological components developed and their integration in a unique,
modular platform. The platform was tested on two sites with the in-
volvement of cancer patients, a large-scale pilot for adults and a small-
scale test for children. The results of these pilot activities are presented
and discussed in detail.
A key conclusion from our work is that the platform has been shown
to be effective in integrating all involved stakeholders through a mul-
ticomponent ICT platform, ensuring continuity and consistency of
clinical management, including providing and sharing information and
care planning, coordinating the care required by the patient. The work
reported in this manuscript provides additional evidence indicating that
continuity is valuable and important to both doctors and patients. It not
only enables health doctors to have an improved relationship with their
patients but also enables them to work more effectively and, most im-
portantly, results in improved clinical outcomes, a finding that is in line
with prior published evidence [71].
Additional key findings from the large-scale pilot demonstrate
mixed evidence regarding improvements for patient empowerment due
(i) to lack of time and (ii) effects of treatment that induced stress and
psychological problems. Nevertheless coping with cancer, including
mood and cancer resilience, improved for the trial arm using the plat-
form. Regarding the small-scale testing in the pilot for children it was
not possible to demonstrate any impact on distress in parents with
children with cancer, due to the limitations on the number of patients
enrolled. Nevertheless, users recognized the usability and the usefulness
of the developed platform.
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Appendix
The user scenarios were developed in an iterative process with all stakeholders. The following Fig. A1 gives a schematic overview of the selected
user scenarios together with the responsible stakeholders, whereas the interested reader is forwarder to the relevant deliverable to see them in their
full detail1. All scenarios translated in use cases and built as tools/apps.
1 http://imanagecancer.eu/download_file/62/294.
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